NOVEL YEAST PROMOTERS SUITABLE FOR EXPRESSION CLONING IN YEAST AND HETEROLOGOUS EXPRESSION OF PROTEINS IN YEAST

Abstract: Novel yeast promoters for either EF1-alpha protein or ribosomal protein S7 gene suitable for expression cloning in yeast and heterologous expression of proteins in yeast. The yeast promoters are preferably active in the pH range 4-11 without peptone and obtained from the yeast strain Yarrowia lipolytica.

Description: TITLE: Novel yeast promoters suitable for expression cloning in yeast and heterologous expression of proteins in yeast. FIELD OF INVENTION BACKGROUND OF THE INVENTION The advent of recombinant DNA techniques has made it possible to select single protein components with interesting properties and produce them on a large scale. This represents an improvement over the previously employed production process using micro-organisms isolated from nature and producing a mix¬ ture of proteins which would either be used as such or separated after the production step. However, the conventional cloning techniques have the drawback that each protein component has to be purified and characterised by its (partial) amino acid sequence before it is possible to prepare synthetic oligonucleo¬ tide probes for hybridisation experiments. Since this is a rather time-consuming process, the cloning of novel proteins might be considerably expedited by using a screening method in- volving selecting clones expressing a desired protein activity, i.e. expression cloning. Recently, a novel method for cloning of fungal enzyme genes by expression cloning in yeast was developed by Dalbøge and Heldt-Hansen (A novel method for efficient expression cloning of fungal enzyme genes. Mol. Gen. Genet. 243 : 253-260. (1994) , WO 93/11249) . This expression cloning technique combines the ability of a yeast strain (e.g. Saccharomyces cerevisiae) to express heterologous genes with the utilisation of sensitive enzyme plate assays. The principle in expression cloning is outlined in figure 1. This method makes it possible to clone enzyme genes independently of knowledge of the amino acid sequence and has proven successful in cloning a number of new enzymes. Even though the above described method already have proven successful, there is still room for improvement. Improvement of the expression cloning technique can be done by identifying new improved promoters, e.g. to increase expression of naturally low expressed enzymes and thereby facilitating the subsequent screening. EP 220864 describes a Yarrowia lipolytica yeast promoter XPR2. The XPR2 yeast promoter is only active at pH above 6.0 on media lacking preferred carbon and nitrogen sources and full induction requires high levels of peptone in the culture medium (Ogrydziak, D.M. , Demain, A.L., and Tannenbaum, S.R. (1977) Biochim. Biophys. Acta. 497 : 525-538.; Ogrydziak, D.M. and Scharf, S.J. (1982). Gen. Microbiol. 128 : 1225-1234.). The demand for pH above 6.0 in the medium makes it dif¬ ficult to screen directly for secreted enzymes that are active only in an acidic environment. Therefore, an object of the present invention, is to provide new improved yeast promoters, especially for use in expression cloning in yeast, but also for heterologous expression of a desired polypeptide in an expression system of choice. SUMMARY OF THE INVENTION The present invention is based on the cloning and cha¬ racterisation of two DNA sequences shown in SEQ ID NO 1 and 2, respectively, which both: l)have yeast promoter activity, and 2)have improved properties for expression cloning in yeast. Further deletion studies on both yeast promoter sequences have identified the most important regions for each yeast promoter. For the yeast promoter shown in SEQ ID NO 1, the most important region is from position -241 to -41 and for the yeast promoter shown in SEQ ID NO 2, it is from position -163 to -3. For further details see example 8. Accordingly, in a first aspect the invention relates to a cloned yeast promoter DNA sequence, which comprises a) the DNA sequence from position -241 to -41 shown in SEQ ID NO 1 , or b) an analogue of the DNA sequence defined in a) which i) is at least 90 % homologous with said DNA sequence, or ii) hybridises with the same nucleotide probe as the DNA sequence defined in a) . In a second aspect the invention relates to a cloned yeast promoter DNA sequence, which comprises a) the DNA sequence from -163 to -3 shown SEQ ID NO 2 , or b) an analogue of the DNA sequence defined in a) which i) is at least 90 % homologous with said DNA sequence, or ii) hybridises with the same nucleotide probe as DNA sequence defined in a) . In a further aspect the invention relates to an expression vector comprising a cloned yeast promoter according to the invention. In a further aspect the invention relates to the use of said expression vector for expression cloning in yeast. Further the invention relates to a process for producing a polypeptide of interest in a yeast host cell, the process com¬ prising transforming a suitable yeast host cell with a recombinant expression vector comprising i) a yeast promotor of the invention and ii) a DNA sequence coding for a polypeptide of interest, culturing the transformed cells under suitable condi- tions to express the polypeptide, and recovering the expressed polypeptide from the culture. Finally the invention relates to the use of a polypeptide produced as described above for various industrial applications. BRIEF DESCRIPTIONS OF DRAWINGS Fig. 1: Flow scheme of expression cloning. Fig. 2: Plasmid used for construction of the genomic libray (A) . The SauA I digested genomic DNA was cloned at the BamHI sites after removal of the kanamycine resistance gene. The kanamycine resistance gene is flanked by two inverted repeats which spoils the ability of the plasmid to replicate unless separated by an insert. (B) Example of an expression vector used for examination of the different yeast promoter sequences. All expression vectors used contain selection markers and sequences for replication in E . coli and Y . lipolytica as in pY3Xl (see figure 2) . The different yeast promoter sequences were cloned as Clal/BamHI fragments and tested in constructs in which either the 43kD Cellulase II (WO 91/17243) or Xylanase I from Humicola insolens (WO 92/17573) were used as reporter genes. Fig.3. Yeast strain POld grown in YP medium added 2% galactose, glucose, giycerol, lactose or maltose. Used to identify optimal conditions for making an POld cDNA library (see example 1) . Fig.4. Frequency of cDNA sequences selected for further exami¬ nation. LI and L2 refer to the library from which the sequences come and the subsequent number refers to the clone number in the library concerned. Variation in starting point of the sequences reflects the cDNA syn¬ thesis events. The sequences that include the most of the 5' end of the sequences were used for further analy¬ sis, (see example 2-7). Fig.5. Strategy used for sequence determination of the L1.41 related genomic DNA. Fig.6. Nucleotide sequence of the relevant part of the L1.41 related genomic DNA (L1.41 is identical to SEQ ID NO 1). The positions are related to the A in the ATG start codon (bold), defined as +1. The putative UAS*boxes HOMOL1 (position ÷191 - ÷180) and RPG (÷179 - ÷168) and the T-rich sequence are underlined. The putative TATA box (÷lll - ÷106) and a pyrimidine-rich sequence (÷85 - ÷58) are double underlined. The putative transcription initiation site (÷56 - ÷53) is written in bold. Nucleotides located from position ÷40 and downstream were also present in the cDNA sequence. Fig.7. The nucleotide sequence and the deduced amino acid se¬ quence of the translation elongation factor EF-loc cDNA from Y . lipolytica . Restriction sites for Hindlll (posi- tion 224) and Kpnl (position 353) . This sequence is identical to SEQ ID No 3. Fig.8. Nucleotide sequence of the L2.17 related genomic DNA (L2.17 is identical to SEQ ID NO 2) . The positions are related to the A in the ATG start codon defined as +1. The putative UAS*boxes HOMOL1 (position ÷273 - ÷262) and RPG (÷247 - ÷236) and the T-rich sequence (present on the opposite strand) are double underlined Putative TATA boxes (÷201 - ÷190) , a TATA-like sequence(÷46 - ÷41) and transcription initiation consensus sequences (÷8, ÷55, ÷15 and ÷13) are underlined. The genomic sequence (in¬ cluding the ATG start codon) also present in the cDNA sequence (165-173) and the 3' splice site (176-178) of the intron are written in bold. Fig.9. The nucleotide sequence and the deduced amino acid sequence of Ribosomal protein S7 cDNA from Y . lipolytica . The Kpnl restriction site (position 445) is underlined. This sequence is identical to SEQ ID No 4. Fig.10. The strategy used for deletion analysis of the TEF gene yeast promoter sequence (seq. ID. No.l) . The part of genomic sequence located upstream the cDNA sequence. (B, C, D) 5' deletions of th sequence in (A) . As shown, neither of the deletions affected the putative elements of the basal yeast promoter region. In edition D, the putative UAS* boxes are deleted. Fig.11. The strategy planned for deletion analysis of the ribo¬ somal protein S7 yeast promoter sequence (seq. ID No. 2) . Successful cloning was only obtained for B, D and F. In D, the putative TATA-box and the putative UAS*boxes are excluded. In F the TATA-like sequence and the four 3 • terminal transcription initiation consensus sequences are excluded. Fig.12. Initial activity measurement of the yeast promoters of the invention (A and B) .SC÷leu growth plate + AZCL Birch xylan substrate (B) . POld XPR2 optimal medium growth plates + AXCL HE-cellulose substrate (C) . XPR2 optimal medium growth plates + AZCL Birch xylan substrate (D) . The vector constructions are described in Table 1. DETAILED DESCRIPTION OF THE INVENTION Cloned yeast promoters In preferred embodiments the present invention provides two cloned yeast promoters. One of the promoters comprises a) the DNA sequence from position -241 to -41 shown in SEQ ID NO 1 , or b) an analogue of the DNA sequence defined in a) which i) is at least 90 % homologous with said DNA sequence, or ii) hybridises with the DNA sequence defined in a) . The other promoter comprises a) the DNA sequence from -163 to -3 shown SEQ ID NO 2 , or b) an analogue of the DNA sequence defined in a) which i) is at least 90 % homologous with said DNA sequence, or ii) hybridises with the DNA sequence defined in a) . The promoters of the invention may comprise additional nucleotides to those specified above. In particular the promoter may comprise nucleotides -407 to -41 of SEQ ID NO 1 or nucleotides -543 to -3 of SEQ ID NO 2. A cloned yeast promoter, refers to a yeast promoter cloned by standard cloning procedure used in genetic engineering to relocate a segment of DNA from its natural location to a dif¬ ferent site where it will be reproduced. The cloning process involves excision and isolation of the desired DNA segment, insertion of the piece of DNA into the vector molecule and in¬ corporation of the recombinant vector into a cell where multiple copies or clones of the DNA segment will be replicated. As defined herein, a DNA sequence analogous to either of the two isolated DNA sequence of the present invention is intended to indicate any yeast promoter DNA sequence, which DNA sequence has one or more of the properties cited under (i)-(ii) above. The yeast promoter DNA sequence of the invention may be isolated from a Yarrowia lipolytica yeast strain, or another or related organism, as will be described in further detail further below (see section "Microbial sources") . Alternatively, the promoter sequence of the invention may be constructed on the basis of the DNA sequence presented as DNA sequence shown in SEQ ID NO 1 or SEQ ID NO 2, e . g . be a sub¬ sequence thereof, or a DNA sequence resulting from introduction of one or more nucleotide substitutions (i.e. deletions, inser¬ tions, substitutions, or addition of one or more nucleotides in the sequence) which do not effect (in particular impair) the yeast promoter activity. Regions which can be modified without significantly effecting the yeast promoter activity can be identified by deletion studies. For further details see example 8. The homology referred to in i) above is determined as the degree of identity between the two sequences indicating a derivation of the first sequence from the second. The homology may suitably be determined by means of computer programs known in the art such as GAP provided in the GCG program package (Neetlleman, S.B. and Wunsch, CD., (1970) , Journal of Molecular Biology, 48, 443-453). Using GAP with the following settings for DNA sequence comparison: GAP creation penalty of 5.0 and GAP extension penalty of 0.3, the coding region of the DNA sequence exhibits a degree of identity preferably of at least 90%, more preferably at least more preferably at least 95%, more preferably at least 97% with any of the DNA sequence shown in SEQ ID No. 1 or 2. The hybridisation referred to in (ii) above is intended to indicate that the analogous DNA sequence hybridises to the yeast promoter DNA sequence under certain specified conditions which are described in detail in the Materials and Methods section hereinafter. The oligonucleotide probe to be used is the DNA sequence from position -241 to -41 in SEQ ID NO 1 or from - 163 to -3 in SEQ ID NO 2. The oligonucleotide probe used herein is preferably a double-stranded DNA probe. The DNA sequence encoding a yeast promoter of the invention can be isolated from a suitable organism by colony hybridisation using a 5'-cDNA sequence from the corresponding coding sequence. An example of a flowscheme for such a cloning strategy is given just below and for further details see example 1-7. Construct a yeast promoter containing cDNA libraries, e.g. a Y. lipolytica cDNA library Determine sequences of 100 arbitrarily chosen clones from each library - examine for repeats Identify the yeast promoter sequences of highly expressed genes by hybridization to a genomic library Clone the yeast promoters in reporter constructs and cha¬ racterize the yeast promoter. Alternatively, the DNA encoding a yeast promoter of the invention may, in accordance with well-known procedures, conveniently be isolated from a suitable source, such as any of the below mentioned organisms, by use of synthetic oligonucleo¬ tide probes prepared on the basis a DNA sequence disclosed here¬ in. For instance, a suitable oligonucleotide probe may be pre- pared on the basis of nucleotide sequences presented as SEQ ID No. 1 or 2. Expression cloning In the present context the term "expression cloning in yeast" refers to the technique described by Dalbøge and Heldt- Hansen (A novel method for efficient expression cloning of fungal enzyme genes. Mol. Gen. Genet. 243 : 253-260. (1994), WO 93/11249) . The principle in the expression cloning technique is further outlined in figure 1. Briefly the principle of the technique is following. When an organism that secretes an enzyme of interest is identified, it is grown at inducing conditions and poly(A) enriched RNA is isolated. A directional cDNA library is constructed in a £. coli /yeast shuttle vector under control of a yeast promoter and E. coli is transformed. Plasmid DNA is isolated and introduced into a yeast strain, e.g. S . cerevisiae . The yeast cells are spread on selective growth plates and replicated to selective and inducing plates which contain the relevant enzyme substrate, e.g. xylan when screening for xylanase activity. The xylan is e.g. added as cross linked insoluble granules, which in the presence of xylanase activity will be degraded, leading to a dyed halo formation around the positive yeast colonies. When a positive yeast colony has been identified and re- tested, the cDNA is isolated and cloned in an A . oryzae expression vector. A. oryzae is transformed which makes large scale pro¬ duction of the enzyme possible (Christensen et al, 1988) . Yeast promoter: Yeast promoter refers to the nucleotide sequence(s) at the 5~end of a structural gene which direct(s) the initiation of transcription. The promoter sequence is to drive the expression of a downstream gene. The promoter drives transcription by providing binding sites to RNA polymerases and other initiation and activation factors. Usually the promoter drives transcription preferentially in the downstream direction. The level of transcription is regulated by the promoter. Thus, in the construction of heterologous promoter/structural gene com¬ binations, the structural gene is placed under the regulatory control of a promoter such that the expression of the gene is controlled by the promoter sequence(s) . The promoter is positioned preferentially upstream to the structural gene and at a distance from the transcription start site that approximates the distance between the promoter and the gene it controls in its natural setting. As it is known in the art, some variation in this distance can be tolerated without loss of promoter function. The transcription efficiency of the promoter may, for instance, be determined by a direct measurement of the amount of mRNA transcription from the promoter, e.g. by Northern blotting or primer extension, or indirectly by measuring the amount of gene product expressed from the promoter. A FastA search (Pearson and Lipman. P.N.A.S. USA 85: 2444- 2448 (1988)) on the GenEMBL database showed significant similarity of the downstream cDNA sequence, controlled by the yeast promoter shown in SEQ ID NO 1, to the translation elongation factor EF-la gene (TEF) of various sources, e.g. Arxula adeninivorans , Neurospora crassa and Saccharomyces cerevisiae . In the present context the term "EF-la yeast promoter" is used to indicate the upstream untranslated region upstream of the ATG start codon for the EF-1 a gene (e.g. ATG start codon in SEQ ID NO 3) which contain most, if not all, features required for expression. For further details see Example 6. A similar FastA search on cDNA sequence, controlled by the yeast promoter shown in SEQ ID NO 2 showed significant similarity to the ribosomal protein S7 (RP s7) of S. cerevisiae and the corresponding ribosomal protein S4 of e.g. D . melanogaster and H. sapiens . In the present context the term "ribosomal protein S7 yeast promoter" is used to indicate the upstream untranslated region upstream of the ATG start codon for the ribosomal protein S7 gene (e.g. ATG start codon in SEQ ID NO 4) which contain most, if not all, features required for expression. For further details see Example 7. Both the EF-la and ribosomal protein S7 are essential for growth of Y . lipolytica . Thus the pH tolerance of both the EF-la yeast promoter and ribosomal protein S7 yeast promoter is as least the pH range where Y . lipolytica is able to growth. For both yeast promoters of the invention this is estimated to be in the pH range preferably from 4-11, more preferably from 4-10, more preferably from 4-9, more preferably from 4-8, more preferably from 5-11, more preferably from 5-10, more preferably from 5-9, more preferably from 5-8. In the context of expression cloning an ideal yeast promoter meet the following criteria: Strength. A strong yeast promoter is a necessary premise for a high expression level, and the low copy number of the arsl8 Fournier, P. et al. Yeast 7:25-36 (1991)) based expression vec- tors makes this demand even more important when Y . lipolytica is used as the host organism. Activity in a suitable medium. In the context of expression cloning a suitable medium is a medium from which it is easy to purify the secreted product for initial characterisation and it is a medium which is selective. Use of a selective medium makes it possible to screen directly for positive clones. pH tolerance. If the enzymes of interest are known to be active only in e.g. an acidic environment, direct screening will only be possible on corresponding plates. pH tolerance is of course limited by the tolerance of the host organism. Inducibility. A tightly regulated yeast promoter makes it possible to separate the growth stage from the expression stage, thereby enabling expression of products which are known to inhibit cell growth. The Yarrowia lipolytica XPR2 yeast promoter of the prior art: The XPR2 gene from Y . lipolytica encodes an inducible alkaline extracelluar protease (AEP) which is the major protein secreted by this yeast (Davidow et al, 1987 b) . Induction of AEP occurs at pH above 6.0 on media lacking preferred carbon and nitrogen sources and full induction requires high levels of peptones in the culture medium (Ogrydziak et al, 1977; Ogrydziak and Scharf, 1982) . The regulation of the XPR2 gene is very complex and not yet fully understood. The fact that the XPR2 yeast promoter is only active at pH above 6.0 on media lacking preferred carbon and nitrogen sources and full induction requires high levels of peptone in the culture medium is highly disadvantageous for the use of such yeast promoter in expression cloning in yeast. The demand for pH above 6.0 in the medium makes it impossible to screen directly for secreted enzymes that are active only in an acidic environment. The presence of peptone in the medium complicates product recovery and purification. Finally the presence of peptone hinders the direct screening for transformants based on LEU2 selection. In contrast to the known XPR2 yeast promoter of Y . lipolytica the yeast promoters of the present invention is active preferably in the pH range from 4 to 11 (see above) , and do not require peptone in the medium or any other ingredients, which seriously complicates product recovery and purification. Therefore the yeast promoter of the invention is highly suitable for use in expression cloning in yeast and recombinant expression in general. A comparative study of the XPR2 yeast promoter and the yeast promoters of the invention is provided in Example 9. In example 9 it is shown that the yeast promoters of the invention is improved compared to the XPR2 yeast promoter, when tested for yeast promoter activity on growth plates, which can be considered as an imitation of a screening event. Microbial Sources In a preferred embodiment, a yeast promoter of the invention is derived from a Yarrowia lipolytica yeast strain. It is at present contemplated that a yeast promoter of the invention, i.e. an analogous yeast promoter, may be obtained from other micro-organisms. For instance, the yeast promoter may be derived from other yeast strains, such as a strain of Saccha¬ romyces cerevisiae. Expression vector In another aspect, the invention provides a recombinant expression vector comprising a yeast promoter of the invention. The expression vector of the invention may be any expression vector that is conveniently subjected to recombinant DNA procedures, and the choice of vector will often depend on the host cell into which it is to be introduced. The expression vector may e.g. be used for achieving expression cloning in yeast or for the production of heterologous polypeptide of interest. In the latter case, the expression vector comprises i) a yeast promoter of the invention and ii) a DNA sequence coding for a polypeptide of interest. In a expression vector for use in expression cloning in yeast, cDNA ^ s to be screened according to the expression cloning technique described in WO 93/11249 should be operable connected to a yeast promoter of the present invention and a terminator sequence (see WO 93/11249) . Further the expression vector may be used to enable recombinant production of a heterologous and/or homologous protein of interest, preferably an enzyme of interest. The procedures used to ligate the DNA sequences coding for the cDNA library, a DNA sequence coding for a protein of interest, the yeast promoter and the terminator, respectively, and to insert them into suitable vectors are well known to persons skilled in the art (cf., for instance, Sambrook et al., (1989), Molecular Cloning. A Laboratory Manual, Cold Spring Harbor, NY) . Yeast host cells In yet another aspect the invention provides a host cell comprising the recombinant expression vector of the invention. Preferably, the host cell of the invention is a eucaryotic cell, in particular a yeast cell. Examples of such yeast host cell include, but are not limited to a strain of Saccharomyces , in particular Saccharo¬ myces cerevisae, Saccharomyces kluyveri or Saccharomyces uvarum , a strain of Schizosaccharomyces sp. , such as Schizosaccharomyceε pombe , a strain of Hansenula sp. , Pichia sp. , Yarrowia sp. , such as Yarrowia lipolytica , or Kluyveromyces sp. , such as Kluyvero- myces lactis . Especially a strain of Yarrowia lipolytica is a suitable host for the present invention. Process of producing a polypeptide In a still further aspect, the present invention provides a process of producing polypeptide of interest, wherein a suitable host cell, which has been transformed with a expression vector comprising i) the yeast promoter of the invention and ii) a DNA sequence coding for a polypeptide of interest, is cultured under conditions permitting the production of the polypeptide, and the resulting polypeptide is recovered from the culture. The polypeptide may be a protein, e.g. an enzyme such as a protease, amylase or lipase. The medium used to culture the transformed host cells may be any conventional medium suitable for growing the host cells in question. The expressed polypeptide of interest may conveniently be secreted into the culture medium and may be re¬ covered therefrom by well-known procedures including separating the cells from the medium by centrifugation or filtration, precipitating proteinaceous components of the medium by means of a salt such as ammonium sulphate, followed by chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like. The invention is described in further detail in the following examples which are not in any way intended to limit the scope of the invention as claimed. MATERIALS AND METHODS General methods If not further specified, all the experimental techniques referred to below were performed by standard techniques within the field of recombinant DNA technology, cf. Sambrook et al., 1989. All experimental techniques include among others construction of plasmids, ligation, transformation, sequencing, hybridiza¬ tion, and etc. Restriction endonucleases were purchased from New England Biolabs and Boehringer Mannheim and used as recommended by the manufacturers. T4 DNA ligase was purchased from New England Biolabs and used as recommended by the manufacturer. Strains, plasmids, and transformation procedures. Bacterial strains used were Eεcherichia coli MC1061 (Wertman, K.F. et al 1986); SJ2 , a derivative of C600 (Raleigh, E.A. et al 1988) ; and DH10BO (Gibco BRL) . The Yarrowia lipolytica strain used was POld (W29 derivative) ura 3-302, leu 2-270, xpr 2-322 a (gift from Claude Gaillardin, Centre de Biotechnologie Agro-Industrielle, France.) Plasmids used are described in table I and figure 2. Those carrying deletions in the cloned yeast promoters are described in figure 10 and 13. All deletions were introduced into pY5TA- 43kD/Xl or pY5RB- 43kD/Xl. Y . lipolytica was transformed by electrotransformation. SJ2 and DH10B were transformed by electrotransformation and MC1061 by ordinary transformation. Enzymes used as reporter genes: 43kD Cellulase II from Humicola insolens described in WO 91/17243. Xylanase I from Humicola insolens described in WO 92/17573. TABLE I. Plasmids used (except those carrying yeast promoter deletions) . Plasmid Use/ relevant features Source pSJ1678 Bacillus/E . coli shuttle vector used for cloning of Sau 3A I digested POld genomic DNA (figure 2) . PUC19 Used for sequence determination of positives Yanisch- from POld genomic library originally cloned Perron, in pSJ1678. C. et al 1985 pYES 2.0 Used for cloning of POld cDNA libraries as Invitroge BstXl /Notl fragments. n USA pY343kD Y . lipolytica expression vector based on the XPR2 yeast promoter and the LEU2 gene as a selection marker. The 43kD cellulase II from Humicola insolens is used as a reporter gene. pY343kD is similar to pY3Xl (figure 2) , where in pY343kD cellulase II is used as reporter gene in stead of Xylanase I. PY3X1 Y . lipolytica expression vector based on the XPR2 yeast promoter and the LEU2 gene as a selection marker. The xylanase I from Humicola insolens is used as a reporter gene, (see figure 2) . PY5TA43k Based on pY343kD. The XPR2 yeast promoter D sequence has been removed as a Clal /BamHI fragment and replaced by the translational elongation factor la yeast promoter sequence edition A cloned in this study, (see figure 10) . PY5TAX1 Based on pY3Xl. The XPR2 yeast promoter sequence has been removed as a Clal/BamHI fragment and replaced by the translational elongation factor la yeast promoter sequence edition A cloned in this study, (see figure 10) PY5RB43k As pY5TA43kD, except that the ribosomal D protein S7 yeast promoter sequence edition B cloned in this study is used as the yeast promoter, (see figure 11) . PY5RBX1 As pY5TAXl, except that the ribosomal protein S7 yeast promoter sequence edition B cloned in this study is used as the yeast promoter, (see figure 11) . PY543kDC Control vector based on pY343kD. The XPR2 V yeast promoter sequence has been removed as a Clal/BamHI fragment and the vector religated after blunt ending by Mung Bean Nuclease treatment. PY5X1CV Control vector based on pY3Xl. The XPR2 yeast promoter sequence has been removed as a Clal/BamHI fragment and the vector religated after blunt ending by Mung Bean Nuclease treatment. Further details of strains: E. coli strains For use in the vector construction work: MC1061 F~ araD139 D (ara-leu) 7696 galElδ galK16 D (lac) X74 rpsL (Str r ) hsdR2 (rjς- m^) mcrA mcrBl As host strain for Yarrowia lipolytica POld cDNA libraries: DH10BH (Gibco BRL) F mcrA D(mrr-hsdRMS-mcrBC) F80dlacZDM15 DIacX74 deoR recAl endAl araD139 D(ara, leu ) 7697 gralU gal K 1 " rpsL nupG As host strain for Yarrowia lipolytica POld genomic library: SJ2: A C600 derivate (Raleigh et al, 1988) . For site-specific mutagenesis on pYl: E . coli BMH71-18 mut S . thi sup E A (lac-pro AB) [ mutS : :TnlO] F' [proAB + lacl q lac Z ΔM15] Yeast strains Yarrowia lipolytica POld: ura 3-302 leu 2-270 xpr 2-322 E129: Mat A lys 11-23 ura 3 -302 leu 2-270 xpr 2-322 E150: Mat B his -1 ura 3-302 leu 2-270 xpr 2 -322 ura 3-302 is a disruption of URA3 leu 2-270 is an internal deletion xpr 2-322 is a deletion removing transcriptional start, ATG, and part of the pre-pro region. Saccharomyces cerevisiae JG169: W 3124: Mat a ura 3 -52 leu 2 - 3 , 112 his 3 -D200 pep4 -1137 D prcl : :HIS3 prbl : :LEU 2 cir + Hansenula polymorpha A16: Transformant are selected on the basis of a defective Leucine gene. Schizosaccharomyces pombe 972: h ura4-294 Kluyveromyces lactiε MW98-8C: Mat a uraA arg lys K + pKDl 0 Transformation of yeast cells: Electro-competent yeast cells This S . cerevisiae protocol was used without modifications to make electro-competent Yarrovia lipolytica POld cells . 1. Inoculate 500 ml YPD with an aliquot from an overnight culture. Grow with vigorous shaking at 30°C to an ODβoo of 1*3 - 1.5 (approximately 1 X 10 8 cells/ml. 2.Divide the culture into two centrifuge bottles and spin at 5000 rpm for 5' at 4°C in a Beckman centrifuge. Discard the supernatant. 3.Resuspend in a total of 500 ml ice-cold sterile water and centrifuge as above. Discard the supernatant. 4.Resuspend in a total of 250 ml. Pool the two 125 ml aliquots into a single bottle and centrifuge as above. Discard the supernatant. 5.Resuspend in 20 ml ice-cold 1 M sorbitol. Transfer to a chilled 30 ml centrifuge tube. Centrifuge as above and discard the supernatant. δ.Resuspend by adding 0.5 ml ice-cold 1 M sorbitol. Store on ice. The cells can be stored at ÷ 80°C for several month. It is very important to keep the culture and all solutions cold durring the treatment of the cells. Culture media and growth conditions. Prior to the construction of cDNA libraries, initial growth experiments with POld were performed in YP medium, with addition of 2 % of the various carbohydrate sources tested. Cells were grown at 30°C. MC1061 and DH10B transformants were grown in LB medium + 100 mg/ml ampicillin. SJ2, transformed with pSJ1678, in which POld genomic DNA was cloned as Sau 3A I fragments, was grown in LB+10 mg/ml chloramphenicol. For Northern blot analysis and contruction of cDNA libraries, POld cultures were grown in YP + 2% glucose or 2% giycerol (library 1 and 2 respectively) at 30°C and cells were harvested late in the logarithmic phase at a optical density of 600 nm (ODeoo) of 5.5. For construction of a genomic library and Southern blot analysis POld cultures were grown in YP-glucose. For cellulase and xylanase assays, positives were precultured in SC.leu medium and the respective inducing growth media inoculated to an OD 60 o of 0.1. Transformants containing XPR2 yeast promoter based vectors were grown in XPR2 optimal medium. SC.leu medium was used as inducing medium for transformants in which the novel yeast promoter sequences were introduced. Transformants were grown in 5 100 ml media in 500 ml bottles at 30°C, 250 rpm. Samples were taken 3 times during the logarithmic phase (SC.leu cultures ODeoo < 0.5, XPR2 optimal medium cultures ODβoo < 10 a nd 3 times during the stationary phase. Extraction of total RNA is performed with guanidinium 0 thiocyanate followed by ultracentrifugation through a 5.7 M CsCl cushion, and isolation of poly(A) + RNA is carried out by oligo(dT) -cellulose affinity chromatography using the procedures described in WO 94/14953. cDNA synthesis: Double-stranded cDNA is synthesized from 5 5 mg poly(A) + RNA by the RNase H method (Gubler and Hoffman (1983) Gene 25:263-269, Sambrook et al. (1989) Molecular cloning: A laboratory manual, Cold Spring Harbor lab., Cold Spring Harbor, NY) using the hair-pin modification developed by F. S. Hagen (pers. comm.) . The poly(A) + RNA (5 mg in 5 ml of 0 DEPC-treated water) is heated at 70°C for 8 min. in a pre- siliconized, RNase-free Eppendorph tube, quenched on ice and combined in a final volume of 50 ml with reverse transcriptase buffer (50 mM Tris-Cl, pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, Bethesda Research Laboratories) containing 1 mM of dATP, dGTP 5 and dTTP and 0.5 mM 5-methyl-dCTP (Pharmacia) , 40 units human placental ribonuclease inhibitor (RNasin, Promega) , 1.45 mg of oligo(dT) i 8 -Not I primer (Pharmacia) and 1000 units Superscript II RNase H reverse transcriptase (Bethesda Research Laboratories) . First-strand cDNA is synthesized by incubating 0 the reaction mixture at 45°C for 1 hour. After synthesis, the mRNA:cDNA hybrid mixture is gelfiltrated through a MicroSpin S- 400 HR (Pharmacia) spin column according to the manufacturer's instructions. After the gelfiltration, the hybrids are diluted in 250 5 ml second strand buffer (20 mM Tris-Cl, pH 7.4, 90 mM KCl, 4.6 mM MgCl 2/ 10 mM (NH 4 ) 2 S0 4 , 0.16 mM bNAD+) containing 200 mM of each dNTP, 60 units E. coli DNA polymerase I (Pharmacia) , 5.25 units RNase H (Promega) and 15 units E. coli DNA ligase (Boehringer Mannheim) . Second strand cDNA synthesis is performed by incubating the reaction tube at 16°C for 2 hours and additional 15 min. at 25°C. The reaction is stopped by addition of EDTA to a final concentration of 20 mM followed by phenol and chloroform extractions. Mung bean nuclease treatment: The double-stranded cDNA is precipitated at -20°C for 12 hours by addition of 2 vols 96% EtOH, 0.2 vol 10 M NH 4 AC, recovered by centrifugation, washed in 70% EtOH, dried and resuspended in 30 ml Mung bean nuclease buffer (30 mM NaAc, pH 4.6, 300 mM NaCl, 1 mM ZnS0 4 , 0.35 mM DTT, 2% giycerol) containing 25 units Mung bean nuclease (Pharmacia) . The single-stranded hair-pin DNA is clipped by in¬ cubating the reaction at 30°C for 30 min. , followed by addition of 70 ml 10 mM Tris-Cl, pH 7.5, 1 mM EDTA, phenol extraction and precipitation with 2 vols of 96% EtOH and 0.1 vol 3 M NaAc, pH 5.2 on ice for 30 min. Blunt-ending with T4 DNA polymerase: The double-stranded cDNAs are recovered by centrifugation and blunt-ended in 30 ml T4 DNA polymerase buffer (20 mM Tris-acetate, pH 7.9, 10 mM MgAc, 50 mM KAc, 1 mM DTT) containing 0.5 mM of each dNTP and 5 units T4 DNA polymerase (New England Biolabs) by incubating the reaction mixture at 16°C for 1 hour. The reaction is stopped by addition of EDTA to a final concentration of 20 mM, followed by phenol and chloroform extractions, and precipitation for 12 hours at -20°C by adding 2 vols 96% EtOH and 0.1 vol 3 M NaAc pH 5.2. Adaptor ligation, Not I digestion and size selection: After the fill-in reaction the cDNAs are recovered by centrifugation, washed in 70% EtOH and dried. The cDNA pellet is resuspended in 25 ml ligation buffer (30 mM Tris-Cl, pH 7.8, 10 mM MgCl 2 , 10 mM DTT, 0.5 mM ATP) containing 2.5 mg non- palindromic BstXI adaptors (Invitrogen) and 30 units T4 ligase (Promega) and incubated at 16°C for 12 hours. The reaction is stopped by heating at 65°C for 20 min. and then cooling on ice for 5 min. The adapted cDNA is digested with Not I restriction enzyme by addition of 20 ml water, 5 ml lOx Not I restriction enzyme buffer (New England Biolabs) and 50 units Not I (New England Biolabs) , followed by incubation for 2.5 hours at 37°C. The reaction is stopped by heating at 65°C for 10 min. The cDNAs are size-fractionated by gel electrophoresis on a 0.8% SeaPlaque GTG low melting temperature agarose gel (FMC) in lx TBE to separate unligated adaptors and small cDNAs. The cDNA is size- selected with a cut-off at 0.7 kb and rescued from the gel by use x>f β-Agarase (New England Biolabs) according to the manu¬ facturer's instructions and precipitated for 12 hours at -20°C by adding 2 vols 96% EtOH and 0.1 vol 3 M NaAc pH 5.2. Construction of directional cDNA libraries. Total RNA was extracted and poly(A)+RNA isolated. From 500 ml cultures (» 2.75 x 10 10 cells) a yield of 1.9 mg and 2.9 mg total RNA was obtained (library 1 and 2 respectively) . Isolation of poly(A)+RNA yielded 1.1 % and 2.2 % (library 1 and 2 respectively) . Double stranded cDNA was synthesised from 5 mg poly(A)+RNA as described. The method includes introduction of a 3' Wotl site by the oligo(dT) -Notl anchor primer. Size estima¬ tion of the double stranded cDNA on 1 % agarose showed a distri¬ bution of the product between 0.3 Kb and 10 Kb. Removal of the single stranded hairpin DNA by Mung bean nuclease treatment and blunt ending with T4 DNA polymerase was followed by ligation of non-palindromic BstXI adaptors. After Notl digest a 5'BstXI 3 'Notl product was obtained. The cDNA was size fractionated on a 0.8 % low melt agarose gel and fragments > 0.8 Kb were purified. Test ligations with different amounts of BstXI /Notl digested pYES 2.0 vectors, followed by electrotransformation of DH10B, did not result in saturation of the vector in any cases. Thus the sizes of the libraries were estimated to be at least 2 x 10 and 3 x 10 5 (library 1 and 2 respectively) . Sequence determination. All sequence determinations were performed on ABI 373 or 377 DNA Sequencer and analysed by use of Sequencerδ 2.1 or 3.0 (Gene Codes Corporation, USA) . Initial sequence determination of cDNA clones was performed only on one strand at the 5' end by use of a single primer. Selected cDNA clones were sequenced on both strands except at the sequence just upstream the poly A tail, were a single strand was sequenced twice with different primers. Sequence determination of positive clones from the genomic libraries was not possible when present in the pSJl678 background, why these inserts were cloned in pUC19 prior to sequence determination of both strands. The genomic insert that responded to the L1.41 based probe was cloned in pUC19 as a Sail fragment, and the insert that responded to the L2.17 based probe was cloned as a Pstl fragment, due to the presence of the remaining practicable cloning sites internal in these inserts. Southern and Northern blots. Southern blot analysis was carried out at standard conditions. For each analysis 4 x 10 mg POld genomic DNA was digested to completion (20 unit enzyme, 3 hours incubation + additional 10 unit enzyme and 2 hours incubation) and fractionated on 1 % Sea Kern GTG agarose (FMC Bioproducts) . To e- xamine for DNase contamination 5 mg genomic DNA was incubated for 5 hours in one of the restriction buffers used for digestion. Polymerase chain reaction (PCR) copies of the re¬ spective cDNA's were used as probes. Radioactive labelling of the DNA by random priming was carried out. Northern blot analysis was carried out at standard conditions. 2 x 2.5 mg poly(A)+RNA from library 1 and 2 was fractionated on 1 % Sea Kern GTG agarose gels. One gel was used for ethidium bromide staining (60' in 0,1M NH 4 Ac, 0.5 mg/ml EtBr) one gel was used for blotting. The same probes as in the Southern blot analysis were used. The membrane was exposed for 45' prior to development. Preparation of total DNA from yeast: The optimal method for preparation of total DNA from yeast depends on the yeast strain. In case of Yarrowia lipolytica a modified S. cerevisiae protocol has been used. 1. Inoculate 20 ml YPD in a 100 ml shake flask and ferment at 30°C O.N. 2.Spin 5' at 5000 rpm. 3.Remove supernatant and resuspend cells in 400 μl 0.9 M Sorbitol, 0.1 M EDTA pH 7.5, 14 mM β-mercaptoethanol. 4.Add 100 μl Novozym (2 mg/ml) and incubate 30' at 37°C. (At this point one should be able to monitor spheroplast 5 formation) 5.Spin 30'' in a microfuge. 6.Remove supernatant and resuspend pellet in 400 μl TE + 5 μl 10X RNase A +T (boil 10' before use). 7.Add 90 μl of fresh made 1.5 ml 0.5 M EDTA pH 8.0 (final 280 10 mM) , 0.6 ml 2 M Tris (final 444 mM) , 0.6 ml 10 % SDS (final 2.2 %) 8. Incubate 30' at 65°C 9.Add 80 μl 5 M KAc. Vortex and leave on ice 30'. 10.Spin 15' at 20.000 G. 15 11.Transfer supernatant to a new tube. Add 1 vol. phenol/chloroform, vortex and leave at 65 °C 10'. Spin 5' at 20.000 G. 12.Transfer upper fase to a new tube and add 1 vol. chloroform. Vortex and spin. Move upper fase to a new tube. Add 3 x vol. 20 96 % EtOH. Mix carefully. 13.Spin 5' at 20.000 G. 14.Wash pellet in 70 % EtOH and dry pellet at R.T. 15.Resuspend pellet gently in 250 μl of a suitable buffer. 25 Construction of a genomic library. Total POld DNA was prepared from a YPD culture. Partial Sau3A I digested DNA was fractionated on a 1 % low melt agarose gel and 1 - 2 Kb fragments were purified by use of β-agarase. DNA fragments were ligated with pSJ1678 from which the 30 kanamycine resistance gene was deleted as a BamHI fragment and introduced into SJ2 by electrotransformation. A library > 45.000 clones was established with a vector background level < 0.5 %. According to the formula by Clark and Carbon (1976) this library size corresponds to a 95 % probability that an arbitrary 35 sequence is represented: N = lnfl.P) / ln(l.f) , where P equals the probability that a given unique DNA sequence is present in a collection of N transformant colonies and f is the fraction of the total genome used as a source for each fragment. The calcu¬ lation relies on the assumptions that the Sau3A I restriction sites are randomly distributed throughout the genome, that all fragments ligate equally well within the size distribution of the fragments (average size = 1.5 Kb), and that the POld genome has a size of 20 Mb. Plasmid DNA was isolated from 20 colonies and cut with Hindlll. Analysis on 1 % agarose gel showed a random distribu- tion of inserts between 1 Kb and 2 Kb (data not shown) . Colony hybridization. Coloni hybridization was performed at standard condi¬ tions. 5 replicas of the genomic library were made (3 for hybri- dization, 1 for plasmid DNA preparation and 1 backup) . 400 bp PCR copies of the 5' end of the respective cDNA clones were used as probes. PCR and cloning of yeast promoter sequences. PCR was performed at standard conditions, except for primer annealing temperature, which was raised to 60°C. All products were purified prior to further use with QlAquick PCR Purification kit (QIAGEN) as recommended by the manufacturer. PCR copies of the identified yeast promoter sequences were cloned in the expression vectors as 5'ClaI 3'BamHI fragments. These cloning sites were introduced by the PCR pri¬ mers. The number of bases flanking the restriction sequences on the primers was selected as recommended by New England Biolabs®. In the Ribosomal protein S7 yeast promoter sequence, a BamHI site was present close to the 5' end. Therefore, only the se¬ quence located downstream this site was introduced in the ex¬ pression vectors. Further, an internal Clal site was present at position > 269 from the putative translational ATG start codon. PCR editions affected by this restriction site were digested with BamHI, purified with QlAquick PCR Purification kit (QIAGEN) , followed by a partial digest with Clal . Relevant fragments were purified from 1.5 % low melt agarose gel prior to ligation and transformation of MC1061. Despite repeated efforts, succesful cloning was only obtained with some of the Ribosomal protein S7 yeast promoter editions. Due to time constraints, this cloning problem was not examined any further. The different PCR copies of the Elongation factor 1 a yeast promoter sequence, and the edition of the Ribosomal protein S7 yeast promoter unaffected by the Clal site were Clal /Baml digested, purified with QlAquick PCR Purification kit (QIAGEN) , and introduced into MC1061. Succesful cloning was verified by Clal/Baml digest of Qiagen DNA preparations and analysis on 2 % agarose gel. All the cloned PCR copies of the yeast promoters were sequenced and compared with the original genomic sequences in order to examine for misincorporations. No errors were detected. Control vectors Control vectors for the enzyme activity experiments were constructed on the basis of pY3- 43kD/Xl. The XPR2 yeast pro¬ moter sequences were removed as Clal/BamHI fragments, vectors were blunt ended by Mung bean nuclease treatment, religated and amplified in MC1061. Succesful nuclease treatment was verified by restriction analysis and confirmed by sequence determination. Enzymatic activity assays: Cellulase I, Cellulase II, and Xylanase I: Activity determination of Cellulase I, Cellulase II, and Xylanase I was made in liquid assays by the use of AZCL (AZurin dyed Cross Linked) substrates (MEGAZYME Australia) . Mix in an eppendorf tube: • 100 - 145 μl optimal buffer • 50 μl supernatant (in case of supernatant samples SI - S3 from xylanase I cultures only 5 μl) sample blank, standard or standard blank. • 100 μl 0.4 % AZCL substrate in milliQ water. All samples are placed on ice durring the treatment. Incubate in a thermomixer at 40 °C, 1200 rpm. for 15 - 45 minutes (Standard ODs 2 o > 0.2) . Spinn 5' at 20.000 G and measure OD 620 of the substrate- grain free supernatants. All samples are measured in duplicates. Sample and standard values are corrected for absorbance of the relevant blank. The activity value is calculated as Sample activity/ Standard activity. Enzyme AZCL substrate Optimal buffer Standard (purified native enzyme) 0.1 M ι. 72 μg/μi Cellulase I HE-Cellulose citrate/phos. diluted 1200 P H times 5.5 0.1 M Tris pH 1.5 μg/μi Cellulase II HE-Cellulose 7.5 diluted 200 times 0.1 M 2 μg/μl diluted Galactanase I Arabinogalactan citrate/phos. 6000 times PH 4.5 0.1 M Tris pH 1.47 μg/μl Xylanase I Birch-xylan 7.0 diluted 30.000 times. Polygalacturonase I (PG I) and Lipase activity : The enzyme activity of supernatants from both PG I and lipase cultures (chapter 5) was measured on substrate-containing plates. 20 μl supernatant from each sample was loaded in wells and the area of the clearing zone was related to the clearing zones of a titration of a known amount of the respective native enzymes. PG I: 1.0 g agarose is added 100 ml 0.1 M citrate/phosphate buffer pH 4.5. The suspension is heated to the boiling point and lg Obipectin (DE 35 %, NN Switzerland) prewetted in 96 % EtOH is added prior discharge of 25 ml aliquots on plates. 20 μl supernatant or standard is added in wells and incubated 24 hours at 30°C. 1 % MTAB (mixed alkyl- 5 trimethylammoniumbromide, Sigma®) is poured over the plates and incubates at RT untill the clearing zones are detectable. Lipase: 2.0 g agarose is added 10 ml IM Tris pH 9, 5 ml 2M CaCl 2 and 85 ml H 2 0. The suspension is heated to the boiling point and a mixture of 0.5 ml Olive oil and 1 ml Triton X-100 is 0 added prior discharge of 25 ml aliquots on plates. 20 μl supernatant or standard is added in wells and incubated 24 hours at 30°C. Western blotting 5 SDS -PAGE electrophoresis, western blotting and immunostaining. 25 ml supernatant from the respective maximum activity per volume samples was loaded in each lane. Hybridization 0 Suitable hybridization conditions for determining hybridization between an nucleotide probe and an "analogous" DNA sequence of the invention may be defined as described below. The oligonu¬ cleotide probe to be used is the DNA sequence from position -241 to -41 in SEQ ID NO 1 or from -163 to -3 in SEQ ID NO 2. The 5 oligonucleotide probe used herein is preferably a double- stranded DNA probe. Hybridization conditions: Suitable conditions for determining hybridization between a 30 nucleotide probe and a homologous DNA or RNA sequence involves presoaking of the filter containing the DNA fragments or RNA to hybridize in 5 x SSC (standard saline citrate) for 10 min, and prehybridization of the filter in a solution of 5 x SSC (Sam¬ brook et al. 1989), 5 x Denhardt'ε solution (Sambrook et al. 35 1989), 0.5 % SDS and 100 μg/ml of denatured sonicated salmon sperm DNA (Sambrook et al. 1989), followed by hybridization in the same solution containing a concentration of lOng/ml of a random-primed (Feinberg, A. P. and Vogelstein, B. (1983) Anal . Biochem . 132:6-13), 32 P-dCTP-labeled (specific activity > 1 x 10 9 cpm/μg ) probe for 12 hours at ca. 45°C. The filter is then washed two times for 30 minutes in 2 x SSC, 0.5 % SDS at pre- ferably not higher than 55°C, more preferably not higher than 60°C, more preferably not higher than 65°C, even more preferably not higher than 70°C, especially not higher than 75°C. Molecules to which the oligonucleotide probe hybridizes under these conditions are detected using a x-ray film. Media: E . coli media: For selective growth of transformants: LB medium (Luria-Bertani) : 1 % Bacto tryptone, 0.5 % Bacto yeast extract, 0.5 % NaCl + relevant antibiotics as described. Growth plates are made with 2 % Bactoagar. For growth of electro-transformed cells for 1 hour, prior plating on selective medium: SOC medium: 2 % Bacto tryptone, 0.5 % Bacto yeast extract, lOmM NaCl, 2.5 mM Kcl, 10 mM MgCl 2 , 10 mM MgS0 4 , 20 mM glucose. Yeast media: Selective medium for Yarrowia lipolytica transformants: Syntetic Complete medium ÷ Leucine 1 liter medium: 100 ml 10X Basal salt 100 ml 10X glucose (20 %) 100 ml 10X Amino acids ÷ leucine + vitamin Add H 2 0 to 1000 ml. Sterile filtrate. Growth plates are made with 1.5 % agarose. Autoclave the agarose in H 2 0 then add the remainder. Amino acid stock solutions: (SIGMA Cell Culture Reagent®) Constituent Final mg/1 Constituent Final mg/1 Adenine sulphate 20 Biotin (vitamin H) 0.05 Uracil 20 Thiamine HCl 5 (vitamin B) Tryptophan 20 myo-INOSITOL 47 Histidine 20 Pyridoxine Hcl 1.2 (vitamin B6) Arginine 20 Pantothenic acid 23 Methionine 20 Tyrosine 30 Isoleucine 30 Lysine 30 Phenylalanine 50 Glutamic acid 100 Aspartic acid 100 Valine 150 Threonine 200 Serine 400 10X Basal salt: 1 liter; 66.8 g Yeast Nitrogen Base w/o amino acids (Difco) , 100 g Succinic acid, 60 g NaOH. Add H 2 0 to 1 liter and sterile filtrate. Inducing medium for XPR2 based Yarrowia lipolytica transformants: XPR2 optimal medium (a modification of the YPDm media (Nicaud, J.M. et al 1989) ) : 0.1 % glucose 0.2 % (w/v) Yeast Extract 10 % (w/v) Proteose Peptone (DIFCO) Bring Yeast Extract and Proteose Peptone to solution in 50 mM NaHP0 4 pH 6.8. Autoclave and add the glucose. For growth plates add 1.5 % agar before autoclavation. YP medium (per 1) : 20 g Bacto peptone, 10 g Bacto yeast extract. EXAMPLES Example 1: Construction of cDNA libraries. A cDNA library can be considered as an image of the tran¬ scriptional activity in the cell at the growth conditions present. The aim was to identify strong yeast promoters that were active at conditions suitable for use in expression cloning. Therefore the ability of strain POld to assimilate various carbohydrate sources was examined prior to the construction of cDNA libraries (figure 3) . Assimilation of carbon compounds in terms of + or „ has been examined for some of the first Y . lipolytica strains isolated (reviewed by Lodder, J. 1970) and a slight variation among the strains was observed. In the present growth experiment carbo¬ hydrates of both categories were tested. The growth experiment (figure 3) clearly demonstrated that strain POld is capable of utilizing glucose and giycerol as carbo- hydrate sources. The indication of weak assimilation of maltose is in agreement with the observations by Lodder. In the attempt to identify not only strong but also inducible yeast promoters, it was decided to construct cDNA libraries from both YP -glucose and -giycerol cultures. The idea was that if the presence of glucose or giycerol caused distinct patterns of induction or repression of yeast promoters (e.g. a glucose repression effect) this would appear in a comparison of sequences from the two libraries. EXAMPLE 2: Analysis of cDNA libraries. An initial sequence determination was performed on 100 clones from each cDNA library in which 300 - 600 nucleotides of the 5' end of the inserts were determined. The sequence data from each library were aligned internally and to each other. In the following the cDNA library from the YP-glucose culture is refered to as LI and the library from the YP-glycerol culture as L2. 7 different sequences from LI were represented twice and two different sequences were represented as triplets. It turned out that one of the pairs came from identical clones which is possible due to the growth of the transformed cells for 1 hour in liquid medium prior transfer to growth plates. 14 different sequences from L2 were represented twice, of which two pairs came from identical clones. Alignment of LI and L2 showed that several sequences from one library also were represented in the other. Four sequences of the 200 clones examined were chosen for further examination (figure 4) : One representing the sequence observed most frequently (A) , one representing the most frequently sequence observed only in LI (B) , one representing the second most observed (C) , and one representing a sequence observed twice in L2 and not in LI (D) . EXAMPLE 3: Comparative measurement of transcription frequency. The detection of a sequence in two or three copies in only one of the cDNA libraries could indicate that different yeast promoter activity was present in the YP -glucose and -giycerol media. To test this, a Northern blot analysis was performed. PCR copies of the selected cDNA sequences were hybridized to poly(A)+RNA from the YP -glucose and -giycerol cultures respectively. If the frequency of the different cDNA sequences reflects the quantity of the corresponding transcripts, unequal intensity of signals could be expected when probes based on the L1.45 or L2.17 sequences were used. The intensity of the signals does not differ in any case, independently of the origin of the poly(A)+RNA, this was not observed at shorter exposure either. These data indicates that no significant repression of transcription has taken place concerning the sequences examined, either in the presence of glucose or giycerol in the medium. EXAMPLE 4 : Copy number analysis. A high frequency of a specific sequence reflects the presence of a strong yeast promoter. This is of course quite a simplification. A high frequency could also be caused by a high mRNA stability or a high copy number of the gene. If all these copies were actively transcriped, the yeast promoter strength in terms of sequence frequency would be correspondingly low. In order to examine for copy number on the genome of the selected genes a Southern blot analysis was carried out. It appears, that the probes based on the L1.41 (A), L1.45 (B) or L2.17 (D) sequences, hybridize at one or two areas on the mem¬ brane, depending on the enzymes used. Sequence determination of the entire cloned cDNA of L1.41 and ~ L2 . 11 (see later) showed that in the case of L1.41, both a HindiI site and a Kpnl site was present in the structural gene, and in case of L2.17 a Kpnl site was present. A PCR copy of the L1.45 sequence was digested with the enzymes employed in the Southern analysis. Electrophoresis on agarose gel showed that an internal Kpnl site was present (data not shown) . This strongly indicate that the POld genome contains only one copy of both L1.41, L1.45 and L2.17. The L2.7 based probe hybridize at several distinct areas of the membrane. Digest of a PCR copy of the L2.7 sequence with the employed enzymes did not reveal an internal presence of these sites (data not shown). This show that the L2.7 sequence is pre¬ sent in several copies in the POld genome. For this reason no attempt was made to identify and test the yeast promoter matching the L2.7 sequence. EXAMPLE 5: Identification of putative yeast promoter sequences by colony hybridization. To identify the yeast promoters matching the strongly expressed transcripts, a POld genomic library was established. 1 - 2 Kb Sau3A I digested POld fragments were cloned in BamHI digested pSJ1678 (figure 2). 45.000 transformants were obtained correspon¬ ding to a 95 % probability of an arbitrary sequence is represented. Prior coloni hybridization, PCR copies of L1.41, L1.45 and L2.17 were digested with Sau3A I. Analysis on agarose gel showed a significant reduction in fragment size (data not shown) , due to the presence of internal Sau3A I sites. In order to increase the probability of identifying sequences located upstream the ATG start codon of the selected genes, 400 bp PCR copies of the 5 ' end of the selected cDNA sequences were used as probes. Colony hybridization resulted in one positive for each probe used. Unfortunately, the positive corresponding to L1.45 was lost during the process of isolating the positives. Hindlll digest showed that the clones responding to the L1.41 and L2.17 based probes contained inserts of approximately 1000 and 1500 bp, respectively. Sequence determination of the positive inserts was not possible when present in the pSJ1678 background and hence the insert were recloned in pUCl9 prior to sequencing. EXAMPLE 6: Sequence determination of the L1.41 related genome and cDNA sequence. The 915 bp L1.41 related genomic DNA was sequenced at both strands as illustrated in figure 5. Alignment of the L1.41 related genomic DNA with the corresponding cDNA revealed a 549 bp overlap between 3' genomic DNA and 5' cDNA, corresponding to a 366 bp sequence in the genomic DNA located upstream the cDNA sequence (figure 6.) The sequence in figure 6 is the same as shown in SEQ ID NO 1. The nucleotide sequence and the deduced amino acid sequence of the L1.41 cDNA is presented in figure 7. The sequence in figure 6 is the same as shown in SEQ ID NO 3. The 1500 bp cDNA clone contains a 1380 bp open reading frame initiated with an ATG codon 41 bp downstream the 5' terminal nucleotide, and terminated with a TAA stop codon 1421 bp down¬ stream the 5' terminal nucleotide, thus predicting a 460-residue polypeptide of 50065 Da. The open reading frame is preceded by a 40 bp 5' -noncoding region and followed by a 60 bp 3' -noncoding region and a poly(A) tail. An initial FastA search (Pearson and Lipman, 1988) on the GenEMBL database showed significant similarity of the Ll.41 cDNA sequence to the translation elongation factor EF-la gene (TEF) of various sources, e.g. Arxula adeninivorans, Neurospora crasεa and Saccharomyces cerevisiae (see appendix II) . GAP alignments (Needleman and Wunsch, 1970) were made with the complete L1.41 cDNA sequence aligned to the TEF gene sequen¬ ces of yeasts A. adeninivorans and S . cerevisiae. 83.8 and 76.4 percent similarity was observed, respectively. At the amino acid level a BLASTX search (Altschul et al, 1990) , on the swissprot database, showed as much as 91 percent identity to the elongation factor la of A. gossypii . To the corresponding genes of C. albicanε, A . adeninivorans and S . cerevisiae 90, 90 and 89 percent identity was observed, respectively. The elongation factor la plays an essential role in protein synthesis in eukaryotic cells by binding the amino-acyl t- RNA to the ribosomes in exhange for the hydrolysis of GTP. EXAMPLE 7: Sequence determination of the L2.17 related genome and cDNA sequence. The 1435 bp L2.17 related genomic DNA was sequenced at both strands. The relevant part of the nucleotide sequence of the L2.17 genomic DNA is shown in figure 8. The sequence in figure 8 is the same as shown in SEQ ID NO 2. Alignment of the L2.17 related genomic DNA with the corresponding cDNA showed that 759 bp of the genomic sequence was located upstream the 5* end of the cDNA sequence. Further, the alignment strongly indicated the presence of an intron of 165 nucleotides: A 16 bp sequence in the genomic DNA (position ,2 - +14) , including the putative ATG start codon, matched perfectly with a sequence located in the 5* end of the cDNA sequence. There was no homology between the genomic DNA and the cDNA in the intervening sequence. The 16 bp genomic sequence was followed by a 5 ' splice site consensus sequence - GTGAGT (figure 8) at position 15 - 20. A 3' splice site consensus sequence - CAG (position 177 - 179) - was present in the 3' end of the 165 nucleotide intron, and an internal consensus sequence for lariat formation - TA 3 CTAAC (position 165 - 173) was present just upstream the 3' consensus sequence. These intron processing signals are very similar to those that define introns in other organisms and the signals present in the intron of the pyruvate kinase-encoding gene (PYK) of Y . lipolytica (table II) . Table II. Consensus intron processing signals from several species and the signals of the Y. lipolytica PYK gene intron.* 5' Internal 3 ' splice lice site conserved site sequence Higher GGT A/G AGT CT A/G A T/C TAG eukaryotes S . pombe GGTA - CT A/G A T/A AG GT T/C N. craεsa - GTA- T - CTAAC T/C AG GT S . cerevisiae GGTATGT TACTAAC T/C AG Y . lipolytica PYK GGTGAGT TACTAAC CAG intron Y . lipolytica GTGAGT TA 3 CTAAC CAG L2.17 intron *Y . lipolytica ~ L2 . il splice sites and signals shown along with the corresponding consensus signals from other organisms and the Y .lipolytica PYK gene. Consensus sequences of higher eukaryotes, S . pombe , N. crasεa, S . cereviεiae (Hindley and Phear, 1984; Kaufer at al, 1985) . Y. lipolytica PYK gene (Strick et al, 1992). As described earlier, it can be quite difficult to predict the transcription initiation site on the basis of consensus sequence data alone. In case of the TEF gene yeast promoter sequence, the presence of a CT rich sequence pointed at a single probable site. In case of the L2.17 genomic sequence, several initiation sites seems possible: Four initiation consensus sequences are located between the putative TATA boxes (position ,201 - ,190) and the ATG start codon (see figure 8) . The fact that the cDNA sequences represented by L2.17 (L2.17 and L2.32 figure 4) both have their 5' end very close to the ATG start codon could indicate that they represent almost full length cDNA clones. This assumption is further supported by the presence of two transcription initiation consensus sequences just upstream the 5' end of the cDNA sequence. The assumption of a transcriptional start site just upstream the ATG start codon disagree with the observation of an average leader sequence length in yeast of 52 bp (reviewed by Yoon and Donahue 1992) . Further, this position of the transcription initiation sites is far out of the range of the transcription initiation window (40-120 bp downstream the ,201 - ,190 TATA bo- xes) . The existence of several possible transcription initiation sites was examined further in a yeast promoter deletion analysis (see below) . The L2.17 cDNA was sequenced at both strands. The nucleo- tide sequence and the deduced amino acid sequence of the L2.17 cDNA is presented in figure 9. The sequence in figure 9 is the same as shown in SEQ ID NO 4. The 853 bp cDNA clone contains a 780 bp open reading frame initiated with an ATG codon 3 bp downstream the 5 ' terminal nucleotide, and is terminated with a TAA stop codon 783 bp downstream the 5' terminal nucleotide, thereby predicting a 260- residue polypeptide of 29193 Da. The open reading frame is preceded by a 2 bp 5' -noncoding region and followed by a 49 bp 3 ' -noncoding region and a poly(A) tail. A FastA search (Pearson and Lipman, 1988) on the GenEMBL database showed similarity of the L2.17 cDNA sequence to the ribosomal protein S7 of S . cereviεiae and the corresponding ribo¬ somal protein S4 of e.g. D . melanogaεter and H . εapiens . GAP alignments (Needleman and Wunch, 1970) showed 69.2 percent similarity to a ribosomal protein S4 cDNA sequence of D . melanogaεter and 68.5 % similarity to exon 1 and exon 2 of the S . cereviεiae ribosomal protein S7. At the amino acid level a BLASTX search (Altschul et al, 1990) , on the swissprot database, showed 82 percent identity to the ribosomal protein S7 of S . cerevisiae , 74 percent identity to the ribosomal protein S4 of D. melanogaεter and 72 percent identity to the ribosomal protein S4 of M . muεculuε and H. sapienε . The ribosomal protein S7 is the largest protein of the 40 S subunit and is essential for growth (Synetos et al 1992) . EXAMPLE 8: Strategy for deletion analyses of the cloned yeast promoters. A detailed analysis of the function of a yeast promoter involves sequence deletion studies as well as DNA/protein and pro¬ tein/protein interaction analyses. Elongation factor l_a (TEF) yeast promoter deletions: The strategy used for deletion studies of the TEF gene yeast promoter sequence (SEQ ID No 1) is shown in figure 10. The 3 ' terminal nucleotide of the yeast promoter sequence was defined to be equal, to the last nucleotide in the 5' part of the genomic sequence that was not represented in the cDNA sequence. This definition is in agreement with the position of the putative transcription initiation site, except for the presence of additional 12 bp located downstream the putative transcription initiation site. All editions of the TEF gene yeast promoter sequence were cloned as Clal/BamHI fragments in pY5 expression vectors carrying cellulase II or xylanase I as reporter genes (see table I. and figure 2) . The yeast promoter sequences were cloned in the expression vectors as PCR copies, in which the 5* Clal site and the 3' BamHI sites were introduced by the PCR primers. The deletion study shown that the DNA sequence from position -241 to position -41 in SEQ ID No 1 comprise the essential element for yeast promoter activity. Ribosomal protein S7 yeast promoter deletions: The planned strategy for deletion analysis of the Ribosomal protein S7 yeast promoter sequence (SEQ ID No 2) is shown in figure 11. Due to the problems with identification of a single probable transcription initiation site, 5' deleted editions with two different 3' ends (position ,3 and ,109) were introduced to the expression vectors. All editions of the ribosomal protein S7 yeast promoter sequence were cloned as Clal/BamHI fragments in pY5 expression vectors carrying cellulase II or xylanase I as reporter genes(see table I. and figure 2). Editions affected by the internal Clal site were prepared by partial Clal digest as described earlier. Succesful cloning was only obtained for B, D and F (figure 11) . The yeast promoter sequences were cloned in the expression vectors as PCR copies, in which the 5' Clal site and the 3 ' BamHI sites were introduced by the PCR primers. The deletion study shown that the DNA sequence from position -163 to position -3 in SEQ ID No 2 comprise the essential element for yeast promoter activity. EXAMPLE 9: Comparative yeast promoter activity studies. The expression vectors based on the yeast promoter sequences of the invention were tested with regard to their suitability as expression cloning tools. The activity level of the yeast promoters was examined both when POld transformants were grown on selective substrate-containing plates, and when transformants were grown in selective liquid medium. Finally the test gene products were examined in a Western blot analysis. As a consequence of the Northern blot analysis results, transformants containing either of the new yeast promoters were grown on/in media in which glucose was used as the carbohydrate source. Activity on growth plates. The activity level of the yeast promoters of the invention was initially tested qualitatively, by growth of POld transformants on selective substrate-containing plates (figure 12. A and B) . Only transformants that include the "full length" editions of the cloned yeast promoters are shown (TEF gene yeast promoter = pY5TA43kD and pY5TAXl, Ribosomal protein S7 yeast promoter = pY5RB43kD and pY5RBXl) . POld transformed with the corresponding expression vectors based on the XPR2 yeast promoter, grown on XPR2 optimal medium substrate-containing plates, are shown in figure 12. C and D. The experiment can be considered as an imitation of a screening event. The growth plate activity experiment show that the new yeast promoters are very effective as screening tools in case of the tested reporter genes. Even in the HE-cellulose substrate assay (which is known to be less sensitive than the xylan substrate based assay) a significant degradation is seen, contrary to the XPR2 yeast promoter based HE-cellulose substrate degradation. As seen, neither of the enzymes were expressed at a detectable level when present in the control vector constructs. Ref erences Altschul, S.F., Gish, W. , Miller, W. , Myers, E.W. and Lipman, D.J. (1990) Basic local alignment search tool. J. Mol. Biol. 215 : 403-410. Christensen, T. , Wøldike, H. , Boel, E. , Mortensen, S.B., Hjortshøj, K. , Thim, L. and Hansen, M.T. (1988) High level expression of recombinant genes in A . oryzae . Biotechnology 6 : 1419-1422. Dalbøge, H. , Heldt-Hansen, H. P. (1994) A novel method for efficient expression cloning of fungal enzyme genes. Mol. Gen. Genet. 243 : 253-260. Davidow, L.S., Apostolakis, D. , O'Donnell, M.M. , Procter, A.R. , Ogrydziak, D.M. , Wing, R.A. , Stasko, I. and DeZeeuw, J.R. (1985) Integrative transformation of the yeast Yarrowia lipolytica . Curr. Genet. 10 : 39-48. Davidow, L.Ξ., Franke, A.E. and DeZeeuw, J.R. (1987 a) Eur. Patent Application 220864. Davidow, L.S., O'Donnell, M.M. , Kaczmarek, F.S., Pereira, D.A., De Zeeuw, J.R. and Franke, A.E. (1987 b) Cloning and sequenceing of the alkaline extracellular protease gene of Yarrowia lipolytica . J. Bacteriol. 169 : 4621-4629. Fournier, P., Guyaneux, L. , Chasles, M. , Gaillardin, C. (1991) Scarcity of arε sequences isolated in a morphogenesis mutant of the yeast Yarrowia lipolytica . YEAST. 7 : 25-36. Fournier, P., Abbas, A., Chasles, M., Kudla, B., Ogrydziak, D. M., Yaver, D. , Xuan, J.-W., Peito, A., Ribet, A.-M., Feynerol, C, He, F., Gaillardin, C. (1993) Colocalization of centromeric and replicative functions on autonomously replicating sequences isolated from the yeast Yarrowia lipolytica . Proc. Natl. Acad. Sci. USA. 90 : 4912-4916. Gubler, U. and Hoffman, B.J. (1983) A simple and very effective method for generating cDNA libraries. Gene. 25 : 263-269. Needleman, S.B. and Wunsch, CD. (1970) A general method applicable to the search for similarities in the amino acid sequence of two proteins. J. Mol. Biol. 48 : 443-453. Ogrydziak, D.M. and Mortimer, R.K. (1977) Genetics of extracellular protease production in Saccharomycopsiε lipolytica . Genentics. 87 : 621-632. Ogrydziak, D.M. , Bassel, J., Contopoulou, R. and Mortimer, R. (1978) Development of genetic techniques and the genetic map of the yeast Saccharomycpoεiε lipolytica . Mol. Gen. Genet. 163 : 229-239. Ogrydziak, D.M. and Scharf, S.J. (1982) Alkaline extracellular protease produced by Saccharomyceε lipolytica CX161-1B.J. Gen. Microbiol. 128 : 1225-1234. Ogrydziak, D.M. (1988) Development of genetic maps of non-conventional yeasts. J. Basic Microbiol. 28 : 185-196. Ota, Y., Oikawa, S., Morimoto, Y. and Minoda, Y. (1984) Nutritional factors causing mycelial development of Saccharomycopεis lipolytica Agr. Biol. Chem. 48 : 1933-1939. Pearson, W.R. and Lipman, D.J. (1988) Improved tools for biological sequence analysis. Proc. Natl. Acad. Sci. USA. 85 : 2444-2448. Raleigh, E.A. , Murray, N.E., Revel, H. , Blumenthal, R.M. , Westaway, D., Reith, A.D., Rigby, P.W.J. , Elhai, J. and Hanahan, D. (1988) MrcA and McrB restriction phenotypes of some E . coli strains and implications for gene cloning. Nucleic Acid Research. 16 : 1563-1575. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. Strick, CA. , James, L.C, O'Donnell, M.M. , Gollaher, M.G. and Franke, A.E. (1992) The isolation and characterization of the pyruvate kinase- encoding gene from the yeast Yarrowia lipolytica. Gene. 118 : 65-72. Synetos, D., Dabeva, M.D. and Warners, J.R. (1992) The yeast ribosomal protein S7 and its genes. J. Biol. Chem. 267 : 3008-3013. Wertman, K.F., Wyman, A.R. and Botstein, D. (1986) Host/vector interactions which affect the viability of recombinant phage lambda clones. Gene. 49 : 253-262 SEQUENCE LISTING SEQ ID NO 1 shows the DNA sequence of the isolated DNA sequence encoding yeast promoter activity, and having homology to the EFl-alpha promotor. This sequence is identical to the L1.41 genomic DNA. See figure 6 for further details. (2) INFORMATION FOR SEQ ID NO: 1: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 409 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Yarrowia lipolytica EFl-alpha yeast promoter (B) STRAIN: Yarrowia lipolytica (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: AGAGACCGGG TTGGCGGCGT ATTTGTGTCC CAAAAAACAG CCCCAATTGC CCCAATTGAC -60 CCCAAATTGA CCCAGTAGCG GGCCCAACCC CGGCGAGAGC CCCCTTCACC CCACATATCA -120 AACCTCCCCC GGTTCCCACA CTTGCCGTTA AGGGCGTAGG GTACTGCAGT CTGGAATCTA -180 CGCTTGTTCA GACTTTGTAC TAGTTTCTTT GTCTGGCCAT CCGGGTAACC CATGCCGGAC -240 GCAAAATAGA CTACTGAAAA TTTTTTTGCT TTGTGGTTGG GACTTTAGCC AAGGGTATAA -300 AAGACCACCG TCCCCGAATT ACCTTTCCTC TTCTTTTCTC TCTCTCCTTG TCAACTCACA -360 CCCGAAATCG TTAAGCATTT CCTTCTGAGT ATAAGAATCA TTCAAAATG 3 SEQ ID NO 2 shows the DNA sequence of the isolated DNA sequence encoding yeast promoter activity, and having homology to the Ribosomal S7 gene yeast promoter. This sequence is identical to the L2.17 genomic DNA. See figure 8 for further details. (2) INFORMATION FOR SEQ ID NO: 2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 952 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (A) ORGANISM: Yarrowia lipolytica Ribosomal S7 gene yeast promoter (B) STRAIN: Yarrowia lipolytica (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: TCGACGGATC CACTTGTATG GCTCCAAGTT CAGTGTACCA AGTAGTTGGT GATGCAGGGA -60 GGGATGTCTC TATCCACCAA TAATGAACTC ATGGGCGAAA TTGTTTCTGT TAAACACTCC -120 AACTGTCGTT TTAAATCTCA TTCTCTTTGC ATTTGGACTC CATTCGCTTC CGTTGGGCCA -180 TATAATCCAT CGTAACGTAC TTTAGATGGA AATTTAGTTA CCTGCTACTT GTCTCAACAC -240 CCCAACAGGG GCTGTTCGAC AGAGGTAATA GAGCGTCAAT GGGTTAATAA AAACACACTG -300 TCGATTTTCA CTCATTGTCT TTATGATATT ACCTGTTTTC CGCTGTTATC AATGCCGAGC -360 ATCGTGTTAT ATCTTCCACC CCAACTACTT GCATTTACTT AACTATTACC TCAACTATTT -420 ACACCCCGAA TTGTTACCTC CCAATAAGTA ACTTTATTTC AACCAATGGG ACGAGAGCAT -480 CTCTGAGAAC ATCGATCTAT CTCTGTCAAT ATTGCCCAGA ATCGTTCGAA AAAAAACACC -540 AAAAGGTTTA CAGCGCCATT ATAAATATAA ATTCGTTGTC AATTCCCCCG CAATGTCTGT -600 TGAAATCTCA TTTTGAGACC TTCCAACATT ACCCTCTCTC CCGTCTGGTC ACATGACGTG -660 ACTGCTTCTT CCCAAAACGA ACACTCCCAA CTCTTCCCCC CCGTCAGTGA AAAGTATACA -720 TCCGACCTCC AAATCTTTTC TTCACTCAAC AAACACAAAA ATGGCCCGAG GACCGTGAGT 20 ATCCCCCACC CCCCGATCAG ATGAGGCACA GACCAGGCTA GCCCATCGCT TTTAGAAGAA 80 GGATAAGGGC TGTTCTGGGT GTGTCAAGAG GAGATGATGA CGAGAAGCAA AGAGCTTCGA 140 CTCAGTCGCC TCTGCCCCCA CGAACTAAAC TAACGCCAGC AAGAAGCATC TC 192 SEQ ID NO 3 shows the DNA sequence and the deduced amino acid sequence of the translation factor EF-lalpha cDNA from Y. lipolytica. This is the sequence corresponding (downstream) of the EF-lalpha yeast promoter shown in SEQ ID NO 1. See figure 7 for further details. (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1500 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (vi) ORIGINAL SOURCE: (A) ORGANISM: EF-lalpha (B) STRAIN: Yarrowia lipolytica (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION:41..1420 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: ATCGTTAAGC ATTTCCTTCT GAGTATAAGA ATCATTCAAA ATG GGA AAG GAA AAG 55 Met Gly Lys Glu Lys 1 5 ACT CAC GTT AAC CTC GTT GTC ATC GGT CAC GTC GAT GCC GGT AAG TCC 103 Thr His Val Asn Leu Val Val lie Gly His Val Asp Ala Gly Lys Ser 10 15 20 ACC ACC ACT GGT CAC CTT ATC TAC AAG TGC GGT GGT ATC GAT AAG CGA 151 Thr Thr Thr Gly His Leu lie Tyr Lys Cys Gly Gly lie Asp Lys Arg 25 30 35 ACC ATC GAG AAG TTC GAG AAG GAG GCC GAC GAG CTT GGA AAG GGT TCT 199 Thr He Glu Lys Phe Glu Lys Glu Ala Asp Glu Leu Gly Lys Gly Ser 40 45 50 TTC AAG TAC GCT TGG GTT CTT GAC AAG CTT AAG GCT GAG CGA GAG CGA 247 Phe Lys Tyr Ala Trp Val Leu Asp Lys Leu Lys Ala Glu Arg Glu Arg 55 60 65 GGT ATC ACC ATT GAT ATT GCT CTC TGG AAG TTC CAG ACC CCT AAG TAC 295 Gly He Thr He Asp He Ala Leu Trp Lys Phe Gin Thr Pro Lys Tyr 70 75 80 85 TAC GTC ACC GTT ATT GAT GCT CCC GGT CAC CGA GAT TTC ATC AAG AAC 343 Tyr Val Thr Val He Asp Ala Pro Gly His Arg Asp Phe He Lys Asn 90 95 100 ATG ATC ACC GGT ACC TCC CAG GCC GAC TGT GCC ATC CTC ATC ATT GCT 391 Met He Thr Gly Thr Ser Gin Ala Asp Cys Ala He Leu He He Ala 105 110 115 GGT GGT GTT GGT GAG TTC GAG GCT GGT ATC TCC AAG GAC GGT CAG ACC 439 Gly Gly Val Gly Glu Phe Glu Ala Gly He Ser Lys Asp Gly Gin Thr 120 125 130 CGA GAG CAC GCT CTG CTC GCT TTC ACC CTC GGT GTC AAG CAG CTG ATT 487 Arg Glu His Ala Leu Leu Ala Phe Thr Leu Gly Val Lys Gin Leu He 135 140 145 GTT GCC ATC AAC AAG ATG GAC TCC GTC AAG TGG TCT CAG GAT CGA TAC 535 Val Ala He Asn Lys Met Asp Ser Val Lys Trp Ser Gin Asp Arg Tyr 150 155 160 165 AAC GAG ATC TGC AAG GAG ACC GCC AAC TTC GTC AAG AAG GTT GGT TAC 583 Asn Glu He Cys Lys Glu Thr Ala Asn Phe Val Lys Lys Val Gly Tyr 170 175 180 AAC CCT AAG TCT GTC CCC TTT GTC CCT ATT TCC GGA TGG AAC GGT GAC 631 Asn Pro Lys Ser Val Pro Phe Val Pro He Ser Gly Trp Asn Gly Asp 185 190 195 AAC ATG ATT GAG GCC TCC ACC AAC TGT GAC TGG TAC AAG GGC TGG ACC 679 Asn Met He Glu Ala Ser Thr Asn Cys Asp Trp Tyr Lys Gly Trp Thr 200 205 210 AAG GAG ACC AAG GCC GGT GAG GTC AAG GGT AAG ACC CTC CTT GAG GCC 727 Lys Glu Thr Lys Ala Gly Glu Val Lys Gly Lys Thr Leu Leu Glu Ala 215 220 225 ATT GAC GCC ATT GAG CCC CCC GTG CGA CCC TCC GAC AAG CCC CTC CGA 775 He Asp Ala He Glu Pro Pro Val Arg Pro Ser Asp Lys Pro Leu Arg 230 235 240 245 CTT CCT CTC CAG GAT GTC TAC AAG ATC GGT GGT ATC GGC ACA GTG CCC 823 Leu Pro Leu Gin Asp Val Tyr Lys He Gly Gly He Gly Thr Val Pro 250 255 260 GTT GGC CGA GTC GAG ACC GGT GTT ATC AAG GCC GGT ATG GTT GTT ACC 871 Val Gly Arg Val Glu Thr Gly Val He Lys Ala Gly Met Val Val Thr 265 270 275 TTC GCT CCC GCC AAC GTG ACC ACT GAG GTC AAG TCT GTC GAG ATG CAC 919 Phe Ala Pro Ala Asn Val Thr Thr Glu Val Lys Ser Val Glu Met His 280 285 290 CAC GAG ATC CTC CCC GAC GGA GGT TTC CCC GGT GAC AAC GTT GGC TTC 967 His Glu He Leu Pro Asp Gly Gly Phe Pro Gly Asp Asn Val Gly Phe 295 300 305 AAC GTC AAG AAC GTT TCC GTC AAG GAT ATC CGA CGA GGT AAC GTT GCC 1015 Asn Val Lys Asn Val Ser Val Lys Asp He Arg Arg Gly Asn Val Ala 310 315 320 325 GGT GAC TCC AAG AAC GAC CCC CCT AAT GGC TGC GAC TCT TTC AAC GCT 1063 Gly Asp Ser Lys Asn Asp Pro Pro Asn Gly Cys Asp Ser Phe Asn Ala 330 335 340 CAG GTC ATT GTT CTT AAC CAC CCC GGT CAG ATC GGT GCT GGT TAC GCT 1111 Gin Val He Val Leu Asn His Pro Gly Gin He Gly Ala Gly Tyr Ala 345 350 355 CCC GTT CTT GAT TGC CAC ACT GCC CAC ATT GCC TGC AAG TTC GAC ACC 1159 Pro Val Leu Asp Cys His Thr Ala His He Ala Cys Lys Phe Asp Thr 360 365 370 CTG ATC GAG AAG ATC GAC CGA CGA ACC GGT AAG AAG ATG GAG GAC TCC 1207 Leu He Glu Lys He Asp Arg Arg Thr Gly Lys Lys Met Glu Asp Ser 375 380 385 CCC AAG TTC ATC AAG TCT GGT GAT GCC GCC ATT GTC AAG ATG GTC CCC 1255 Pro Lys Phe He Lys Ser Gly Asp Ala Ala He Val Lys Met Val Pro 390 395 400 405 TCC AAG CCC ATG TGT GTT GAG GCC TTC ACT GAG TAC CCC CCT CTT GGT 1303 Ser Lys Pro Met Cys Val Glu Ala Phe Thr Glu Tyr Pro Pro Leu Gly 410 415 420 CGA TTC GCC GTC CGA GAC ATG CGA CAG ACC GTT GCT GTC GGT GTC ATC 1351 Arg Phe Ala Val Arg Asp Met Arg Gin Thr Val Ala Val Gly Val He 425 430 435 AAG TCC GTC GAG AAG TCC GAC AAG GCT GGT GGA AAG GTC ACC AAG GCT 1399 Lys Ser Val Glu Lys Ser Asp Lys Ala Gly Gly Lys Val Thr Lys Ala 440 445 450 GCC CAG AAG GCT GCC AAG AAA TAAGCTGCTT GTACCTAGTG CAACCCCAGT 1450 Ala Gin Lys Ala Ala Lys Lys 455 460 TTGTTAAAAA TTAGTAGTCA AAAACTTCTG AGTTAAAAAA AAAAAAAAAA 1500 SEQ ID NO 4 shows the DNA sequence and the deduced amino acid sequence of the ribosomal protein s7 cDNA from Y. lipolytica. This is the sequence corresponding (downstream) of the ribosomal protein s7 yeast promoter shown in SEQ ID NO 2. See figure 9 for further details. (2) INFORMATION FOR SEQ ID NO: 4 (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 853 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (vi) ORIGINAL SOURCE: (A) ORGANISM: Ribosomal protein S7 (B) STRAIN: Yarrowia lipolytica (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATIONS..782 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4 AA ATG GCC CGA GGA CCC AAG AAG CAT CTC AAG CGA CTC GCA GCT CCC 47 Met Ala Arg Gly Pro Lys Lys His Leu Lys Arg Leu Ala Ala Pro 465 470 475 TCC CAC TGG ATG CTG GAC AAG CTG TCC GGC ACC TAC GCT CCC CGA TCG 95 Ser His Trp Met Leu Asp Lys Leu Ser Gly Thr Tyr Ala Pro Arg Ser 480 485 490 TCT GCC GGT CCC CAC AAG CTG CGA GAG TCT CTG CCT CTC GTC ATC TTC 143 Ser Ala Gly Pro His Lys Leu Arg Glu Ser Leu Pro Leu Val He Phe 495 500 505 CTG CGA AAC CGT CTC AAG TAC GCC CTG AAC GGC CGA GAG GTT AAC GCC 191 Leu Arg Asn Arg Leu Lys Tyr Ala Leu Asn Gly Arg Glu Val Asn Ala 510 515 520 ATT CTC ATG CAG CGA CTG GTC AAG GTC GAC GGC AAG GTC CGA ACC GAC 239 He Leu Met Gin Arg Leu Val Lys Val Asp Gly Lys Val Arg Thr Asp 525 530 535 TCC ACT TTC CCC GCT GGC TTC ATG GAT GTC ATC CAG CTC GAG AAG ACC 287 Ser Thr Phe Pro Ala Gly Phe Met Asp Val He Gin Leu Glu Lys Thr 540 545 550 555 GGC GAG AAC TTC CGA CTT GTC TAC GAC GTC AAG GGC CGA TTT GCC GTC 335 Gly Glu Asn Phe Arg Leu Val Tyr Asp Val Lys Gly Arg Phe Ala Val 560 565 570 CAC CGA ATC ACC GAT GAG GAG GCT GCT TAC AAG CTC GGC AAG GTC AAG 383 His Arg He Thr Asp Glu Glu Ala Ala Tyr Lys Leu Gly Lys Val Lys 575 580 585 CGA GTC CAG GTT GGC AAG AAG GGT ATC CCC TAC CTC GTC ACC CAC GAC 431 Arg Val Gin Val Gly Lys Lys Gly He Pro Tyr Leu Val Thr His Asp 590 595 600 GGC CGA ACC ATC CGG TAC CCC GAC CCT CTC ATC AAG GTC AAC GAC ACC 479 Gly Arg Thr He Arg Tyr Pro Asp Pro Leu He Lys Val Asn Asp Thr 605 610 615 GTC AAG ATC GAC CTG GCC ACC GGC AAG ATC ACC TCT TTC GTC AAG TTT 527 Val Lys He Asp Leu Ala Thr Gly Lys He Thr Ser Phe Val Lys Phe 620 625 630 635 GAG AAC GGT AAC ATT GTC ATG ACC ACC GGA GGT CGA AAC ATG GGC CGA 575 Glu Asn Gly Asn He Val Met Thr Thr Gly Gly Arg Asn Met Gly Arg 640 645 650 GTC GGC ACC ATC ACC CAC CGA GAG CGA CAT GAG GGT GGC TTC GAT ATC 623 Val Gly Thr He Thr His Arg Glu Arg His Glu Gly Gly Phe Asp He 655 660 665 GTC CAC ATC AAG GAC GCT CTT GAC AAC CAG TTT GTT ACC CGA CTC ACT 671 Val His He Lys Asp Ala Leu Asp Asn Gin Phe Val Thr Arg Leu Thr 670 675 680 AAC GTT TTC GTT ATC GGT GAG GGC AAC AAG TCT CTC ATC TCT CTG CCC 719 Asn Val Phe Val He Gly Glu Gly Asn Lys Ser Leu He Ser Leu Pro 685 690 695 AAG GGC AAG GGT ATC AAG CTC TCC ATT GCT GAG GAG CGA GAT GCC CGA 767 Lys Gly Lys Gly He Lys Leu Ser He Ala Glu Glu Arg Asp Ala Arg 700 705 710 715 CGA GCC AAG CAG GAG TAAGTTCAGA TTGGAACAAC ATTGGTTTAG CTAAAAAAAA 822 Arg Ala Lys Gin Glu 720 GGATTCATGT TTAAAAAAAA AAAAAAAAAA A 853

Claims: CLAIMS 1. A cloned yeast promoter DNA sequence, which comprises a) the DNA sequence from position -241 to -41 shown in SEQ ID NO 1 , or b) an analogue of the DNA sequence defined in a) which i) is at least 90 % homologous with said DNA sequence, or ii) hybridises with the same nucleotide probe as defined in a) . 2. The yeast promoter according to claim 1, wherein said DNA sequence in a) is from position -407 to -41 in SEQ ID NO 1. 3. The yeast promoter according to claim 1 or 2 , wherein the yeast promoter is obtainable from a yeast. 4. The yeast promoter according to claim 3, wherein a yeast is a strain of Yarrowia lipolytica . 5. The yeast promoter according to any of claims 1-4, wherein the yeast promoter is a promoter of the EF-la protein. 6. A cloned yeast promoter DNA sequence, which comprises a) the DNA sequence from -163 to -3 shown SEQ ID NO 2 , or b) an analogue of the DNA sequence defined in a) which i) is at least 90 % homologous with said DNA sequence, or ii) hybridises with the same nucleotide probe as defined in a) . 7. The yeast promoter according to claim 6, wherein said DNA sequence in a) is from position -543 to -3 in SEQ ID NO 2. 8. The yeast promoter according to claim 6 or 7 , wherein the yeast promoter is obtainable from a yeast. 9. The yeast promoter according to claim 8, wherein said yeast is a strain of Yarrowia lipolytica . 10. The yeast promoter according to any of claims 6-9, wherein the yeast promoter is a promoter of the ribosomal protein S7 gene. 11. The yeast promoter according to any of claim 1 to 5 or any of claim 6 to 10, which is especially useful for expression cloning in yeast, characterised by: i) having promoter activity in a selective medium, ii) having promoter activity in a medium where it is easy to purify a secreted polypeptide, e.g. a medium which do not comprise degraded protein and iii) having promoter activity at least in the pH range from 4 to 11. 12. The promoter according to claim 11, wherein the medium under iii) do not comprise peptone. 13. The promoter according to claim 11, wherein the pH range is from 5 to 9. 14. An expression vector comprising an yeast promoter according to any of claims 1-13. 15. An expression cloning method in yeast, comprising (a) cloning, in expression vectors according to claim 14, a DNA library from an organism suspected of producing one or more proteins of interest, (b) transforming suitable yeast host cells with said vectors, (c) culturing the host cells under suitable conditions to express any protein of interest encoded by a clone in the DNA library, and (d) screening for positive clones by determining any activity of a protein expressed in step (c) . 16. The method according to claim 14, wherein said yeast is a strain of Yarrowia lipolytica . 17. A recombinant expression vector comprising i)a promotor according to any of claims 1 to 5 or 6 to 10 or 11 to 13 and, 5 ii) a DNA sequence coding for a protein of interest. 18. The recombinant expression vector according to claim 17, wherein said promotor is according to any of claims 1 to 5. 10 19. The recombinant expression vector according to claim 17, wherein said promotor is according to any of claims 6 to 10. 20. The recombinant expression vector according to claim 17, wherein said promotor is according to any of claim 11 to 13. 15 21. A yeast host cell transformed with a recombinant expression vector according to any of claims 17-20. 22. A process for producing a protein in yeast comprising 20 culturing a yeast host cell transformed with a recombinant expression vector according to any of claims 17-20 under conditions permitting production of said protein, and recovering the resulting protein from the culture. 25 23. The process according to claim 22, wherein said yeast host cell is a strain of Yarrowia lipolytica 24. Use of a produced protein according to claim 22 for various industrial applications. 30 25. The use according to claim 24, wherein said produced protein is an enzyme.

Inventors: DALBOEGE HENRIK, MUELLER SVEN, DALBOEGE, HENRIK, MUELLER, SVEN
Applicants: DALBOEGE HENRIK, MUELLER SVEN, NOVONORDISK AS, DALBOEGE, HENRIK, MUELLER, SVEN, NOVO NORDISK A/S
Application year: 1997
Main classification: C12N15
IPC codes: C07K14, C12N1, C12N15